Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gmeb2
|
ENSMUSG00000038705.7 | glucocorticoid modulatory element binding protein 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_181288015_181288500 | Gmeb2 | 222 | 0.866509 | 0.84 | 8.1e-16 | Click! |
chr2_181287727_181287922 | Gmeb2 | 192 | 0.887374 | 0.81 | 9.0e-14 | Click! |
chr2_181287325_181287720 | Gmeb2 | 448 | 0.685444 | 0.75 | 5.0e-11 | Click! |
chr2_181253341_181253492 | Gmeb2 | 2715 | 0.140985 | 0.53 | 3.2e-05 | Click! |
chr2_181278006_181278157 | Gmeb2 | 1 | 0.955227 | 0.46 | 4.4e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_14351950_14353283 | 12.09 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr6_38354805_38354976 | 10.19 |
Zc3hav1 |
zinc finger CCCH type, antiviral 1 |
287 |
0.86 |
chr15_97746697_97747016 | 9.02 |
Rapgef3 |
Rap guanine nucleotide exchange factor (GEF) 3 |
2016 |
0.22 |
chr11_83224251_83224525 | 8.02 |
Gm11427 |
predicted gene 11427 |
66 |
0.72 |
chr3_116562756_116563068 | 7.55 |
Lrrc39 |
leucine rich repeat containing 39 |
61 |
0.93 |
chr6_87662289_87662458 | 7.05 |
Gm44097 |
predicted gene, 44097 |
4619 |
0.13 |
chrX_7899224_7899430 | 6.60 |
Timm17b |
translocase of inner mitochondrial membrane 17b |
30 |
0.51 |
chr6_149141174_149141634 | 6.49 |
Etfbkmt |
electron transfer flavoprotein beta subunit lysine methyltransferase |
109 |
0.95 |
chr7_19227944_19228418 | 6.46 |
Opa3 |
optic atrophy 3 |
153 |
0.89 |
chr5_23432721_23432928 | 6.43 |
5031425E22Rik |
RIKEN cDNA 5031425E22 gene |
485 |
0.7 |
chr14_70336335_70336839 | 6.35 |
Slc39a14 |
solute carrier family 39 (zinc transporter), member 14 |
2389 |
0.19 |
chr10_17653857_17654030 | 6.16 |
Gm47771 |
predicted gene, 47771 |
4570 |
0.27 |
chr12_69683796_69683951 | 5.79 |
Sos2 |
SOS Ras/Rho guanine nucleotide exchange factor 2 |
2021 |
0.28 |
chr5_137349031_137350198 | 5.64 |
Ephb4 |
Eph receptor B4 |
495 |
0.62 |
chr6_120832514_120832665 | 5.50 |
Bcl2l13 |
BCL2-like 13 (apoptosis facilitator) |
3623 |
0.17 |
chr1_82184058_82184248 | 5.46 |
Gm9747 |
predicted gene 9747 |
48959 |
0.13 |
chr19_46668309_46668590 | 5.37 |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
1064 |
0.36 |
chr4_40139669_40139825 | 5.34 |
Aco1 |
aconitase 1 |
3334 |
0.24 |
chr16_87612556_87612731 | 5.31 |
Gm22808 |
predicted gene, 22808 |
8477 |
0.2 |
chr3_51231555_51231775 | 5.31 |
Gm38357 |
predicted gene, 38357 |
252 |
0.89 |
chr15_73154519_73155066 | 5.14 |
Ago2 |
argonaute RISC catalytic subunit 2 |
23055 |
0.18 |
chr9_46215286_46215938 | 5.12 |
Sik3 |
SIK family kinase 3 |
3959 |
0.12 |
chr18_56870974_56871252 | 5.11 |
Gm18087 |
predicted gene, 18087 |
44975 |
0.14 |
chr11_11733080_11733257 | 5.10 |
Gm12000 |
predicted gene 12000 |
36729 |
0.13 |
chr19_53313026_53314073 | 4.99 |
Mxi1 |
MAX interactor 1, dimerization protein |
483 |
0.75 |
chr13_46930401_46930639 | 4.94 |
Kif13a |
kinesin family member 13A |
653 |
0.61 |
chr5_123196731_123197228 | 4.94 |
Gm43409 |
predicted gene 43409 |
5391 |
0.11 |
chr12_110978382_110979023 | 4.89 |
Ankrd9 |
ankyrin repeat domain 9 |
84 |
0.95 |
chr17_47909349_47909983 | 4.89 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr13_59738884_59739054 | 4.82 |
1700014D04Rik |
RIKEN cDNA 1700014D04 gene |
3781 |
0.09 |
chr1_151619279_151619636 | 4.75 |
Fam129a |
family with sequence similarity 129, member A |
47961 |
0.12 |
chr7_75656304_75656471 | 4.73 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
12202 |
0.18 |
chr15_55922946_55923097 | 4.70 |
Gm46516 |
predicted gene, 46516 |
381 |
0.83 |
chr6_140546653_140546821 | 4.69 |
Plekha5 |
pleckstrin homology domain containing, family A member 5 |
2584 |
0.34 |
chr1_120267731_120267916 | 4.69 |
Steap3 |
STEAP family member 3 |
2539 |
0.35 |
chr1_184675628_184676155 | 4.66 |
Gm38358 |
predicted gene, 38358 |
19143 |
0.14 |
chr12_99457855_99458149 | 4.59 |
Foxn3 |
forkhead box N3 |
7905 |
0.2 |
chr9_44567755_44567911 | 4.59 |
Cxcr5 |
chemokine (C-X-C motif) receptor 5 |
5956 |
0.09 |
chr16_4541512_4542439 | 4.52 |
Srl |
sarcalumenin |
159 |
0.93 |
chr2_167924845_167925406 | 4.44 |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
6932 |
0.19 |
chr5_139382833_139383061 | 4.42 |
Gpr146 |
G protein-coupled receptor 146 |
2366 |
0.18 |
chr5_109557850_109558797 | 4.40 |
Crlf2 |
cytokine receptor-like factor 2 |
613 |
0.67 |
chr10_80114596_80114882 | 4.37 |
Stk11 |
serine/threonine kinase 11 |
1064 |
0.3 |
chr2_173736867_173737587 | 4.36 |
Vapb |
vesicle-associated membrane protein, associated protein B and C |
284 |
0.88 |
chr16_55781925_55782128 | 4.33 |
Gm26369 |
predicted gene, 26369 |
2882 |
0.26 |
chr4_132515167_132515846 | 4.29 |
Sesn2 |
sestrin 2 |
5005 |
0.1 |
chr11_74831594_74833056 | 4.28 |
Mnt |
max binding protein |
1405 |
0.31 |
chr19_53325625_53325916 | 4.22 |
Gm30541 |
predicted gene, 30541 |
27 |
0.97 |
chr7_126862086_126862870 | 4.19 |
Hirip3 |
HIRA interacting protein 3 |
3 |
0.57 |
chr9_61370339_61371660 | 4.17 |
Gm10655 |
predicted gene 10655 |
628 |
0.63 |
chr8_25980319_25980470 | 4.14 |
Hgsnat |
heparan-alpha-glucosaminide N-acetyltransferase |
3641 |
0.16 |
chr16_90177436_90177587 | 4.14 |
Gm7307 |
predicted gene 7307 |
14331 |
0.15 |
chr17_45972523_45972687 | 4.10 |
Gm49805 |
predicted gene, 49805 |
10746 |
0.18 |
chr1_39425558_39425731 | 4.04 |
Gm37265 |
predicted gene, 37265 |
5712 |
0.18 |
chr11_102407992_102408317 | 4.01 |
Slc25a39 |
solute carrier family 25, member 39 |
208 |
0.87 |
chr5_130200680_130200989 | 4.01 |
Rabgef1 |
RAB guanine nucleotide exchange factor (GEF) 1 |
6219 |
0.1 |
chr3_116737523_116737690 | 3.99 |
Slc35a3 |
solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member 3 |
24775 |
0.11 |
chr11_77372346_77372497 | 3.98 |
Ssh2 |
slingshot protein phosphatase 2 |
19016 |
0.17 |
chr13_98810686_98810846 | 3.97 |
Fcho2 |
FCH domain only 2 |
4387 |
0.14 |
chr6_73232141_73232347 | 3.97 |
Gm40377 |
predicted gene, 40377 |
9194 |
0.17 |
chr2_29649364_29649524 | 3.95 |
Rapgef1 |
Rap guanine nucleotide exchange factor (GEF) 1 |
5629 |
0.22 |
chr3_144110778_144110959 | 3.94 |
Gm34078 |
predicted gene, 34078 |
24886 |
0.21 |
chr4_11147050_11147201 | 3.93 |
Gm11830 |
predicted gene 11830 |
2415 |
0.18 |
chr3_98859741_98859892 | 3.92 |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
22 |
0.96 |
chr11_6444058_6445126 | 3.92 |
H2az2 |
H2A.Z histone variant 2 |
149 |
0.88 |
chr12_37241492_37241709 | 3.90 |
Agmo |
alkylglycerol monooxygenase |
41 |
0.99 |
chr6_134700538_134701162 | 3.89 |
Borcs5 |
BLOC-1 related complex subunit 5 |
700 |
0.61 |
chr6_38834841_38835083 | 3.88 |
Hipk2 |
homeodomain interacting protein kinase 2 |
2262 |
0.35 |
chr4_86690175_86690553 | 3.87 |
Plin2 |
perilipin 2 |
20304 |
0.17 |
chr6_143166517_143167346 | 3.85 |
Etnk1 |
ethanolamine kinase 1 |
290 |
0.88 |
chr1_37347409_37347570 | 3.81 |
Inpp4a |
inositol polyphosphate-4-phosphatase, type I |
9908 |
0.14 |
chr15_80083248_80084015 | 3.80 |
Rpl3 |
ribosomal protein L3 |
225 |
0.75 |
chr19_32359184_32359393 | 3.79 |
Sgms1 |
sphingomyelin synthase 1 |
9972 |
0.19 |
chr6_122393718_122393882 | 3.78 |
1700063H04Rik |
RIKEN cDNA 1700063H04 gene |
2421 |
0.2 |
chr8_117198420_117198657 | 3.74 |
Gan |
giant axonal neuropathy |
40401 |
0.14 |
chr4_151823125_151823276 | 3.73 |
Camta1 |
calmodulin binding transcription activator 1 |
38450 |
0.17 |
chr7_133744777_133745015 | 3.71 |
Gm45670 |
predicted gene 45670 |
2728 |
0.17 |
chr16_22891950_22892305 | 3.69 |
Ahsg |
alpha-2-HS-glycoprotein |
82 |
0.95 |
chr3_51230204_51230396 | 3.68 |
Gm38357 |
predicted gene, 38357 |
1617 |
0.3 |
chr8_116581419_116581617 | 3.68 |
Dynlrb2 |
dynein light chain roadblock-type 2 |
76503 |
0.1 |
chr5_137786077_137787112 | 3.67 |
Mepce |
methylphosphate capping enzyme |
69 |
0.92 |
chr15_98512818_98512995 | 3.66 |
Snora34 |
small nucleolar RNA, H/ACA box 34 |
6947 |
0.07 |
chr10_80754890_80755065 | 3.64 |
Dot1l |
DOT1-like, histone H3 methyltransferase (S. cerevisiae) |
229 |
0.84 |
chr1_181334651_181334972 | 3.63 |
Cnih3 |
cornichon family AMPA receptor auxiliary protein 3 |
17817 |
0.15 |
chr5_36695830_36696401 | 3.63 |
D5Ertd579e |
DNA segment, Chr 5, ERATO Doi 579, expressed |
91 |
0.96 |
chr19_61266773_61267173 | 3.63 |
Gm50357 |
predicted gene, 50357 |
9184 |
0.13 |
chr18_39560855_39561006 | 3.62 |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
41509 |
0.17 |
chr8_83332377_83333157 | 3.60 |
Elmod2 |
ELMO/CED-12 domain containing 2 |
281 |
0.87 |
chr11_107992099_107992280 | 3.55 |
Gm11657 |
predicted gene 11657 |
1833 |
0.29 |
chr3_65658208_65659857 | 3.55 |
Mir8120 |
microRNA 8120 |
256 |
0.89 |
chr2_28582646_28583374 | 3.54 |
Gtf3c5 |
general transcription factor IIIC, polypeptide 5 |
22 |
0.95 |
chr9_103208178_103208329 | 3.54 |
Trf |
transferrin |
3753 |
0.2 |
chr15_31224173_31224992 | 3.52 |
Dap |
death-associated protein |
22 |
0.98 |
chr11_116178578_116178738 | 3.51 |
Acox1 |
acyl-Coenzyme A oxidase 1, palmitoyl |
2556 |
0.14 |
chr8_84965502_84966385 | 3.50 |
Rnaseh2a |
ribonuclease H2, large subunit |
18 |
0.92 |
chr11_116087310_116087960 | 3.50 |
Wbp2 |
WW domain binding protein 2 |
640 |
0.54 |
chr6_36175191_36175478 | 3.49 |
Gm43443 |
predicted gene 43443 |
13765 |
0.28 |
chr6_120039566_120039987 | 3.49 |
Wnk1 |
WNK lysine deficient protein kinase 1 |
1104 |
0.47 |
chr19_32221921_32222099 | 3.46 |
Sgms1 |
sphingomyelin synthase 1 |
10997 |
0.22 |
chr8_72303720_72304021 | 3.46 |
Gm10282 |
predicted pseudogene 10282 |
1390 |
0.29 |
chr11_100938783_100940230 | 3.44 |
Stat3 |
signal transducer and activator of transcription 3 |
27 |
0.97 |
chr13_74733722_74734048 | 3.44 |
Cast |
calpastatin |
346 |
0.89 |
chr19_41848562_41848864 | 3.42 |
Frat2 |
frequently rearranged in advanced T cell lymphomas 2 |
581 |
0.67 |
chr7_73556757_73556908 | 3.41 |
1810026B05Rik |
RIKEN cDNA 1810026B05 gene |
912 |
0.43 |
chr18_42510920_42511513 | 3.41 |
Tcerg1 |
transcription elongation regulator 1 (CA150) |
271 |
0.91 |
chr19_29063875_29064186 | 3.40 |
Gm9895 |
predicted gene 9895 |
3317 |
0.15 |
chr9_83893873_83894077 | 3.39 |
Gm36278 |
predicted gene, 36278 |
31047 |
0.13 |
chr17_84167487_84167639 | 3.38 |
Gm19696 |
predicted gene, 19696 |
11123 |
0.15 |
chr14_70208100_70208580 | 3.37 |
Gm49417 |
predicted gene, 49417 |
589 |
0.45 |
chr4_117189603_117189774 | 3.35 |
Gm25099 |
predicted gene, 25099 |
254 |
0.78 |
chr1_36813442_36813733 | 3.33 |
Tmem131 |
transmembrane protein 131 |
2999 |
0.2 |
chr1_82637507_82637673 | 3.33 |
n-R5s213 |
nuclear encoded rRNA 5S 213 |
2577 |
0.25 |
chr8_95080933_95081107 | 3.32 |
Katnb1 |
katanin p80 (WD40-containing) subunit B 1 |
166 |
0.91 |
chr17_12378113_12378280 | 3.31 |
Plg |
plasminogen |
412 |
0.81 |
chr11_110010816_110011149 | 3.30 |
Abca8b |
ATP-binding cassette, sub-family A (ABC1), member 8b |
15137 |
0.2 |
chr6_55342334_55342687 | 3.29 |
Aqp1 |
aquaporin 1 |
6078 |
0.17 |
chr16_49905313_49905464 | 3.29 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
38555 |
0.21 |
chr19_32181834_32182000 | 3.28 |
Sgms1 |
sphingomyelin synthase 1 |
14511 |
0.21 |
chr6_138424907_138425582 | 3.27 |
Lmo3 |
LIM domain only 3 |
629 |
0.69 |
chr1_91080381_91080716 | 3.27 |
Lrrfip1 |
leucine rich repeat (in FLII) interacting protein 1 |
26962 |
0.16 |
chr16_91010545_91010981 | 3.26 |
Synj1 |
synaptojanin 1 |
298 |
0.61 |
chr11_4229962_4230131 | 3.24 |
Gm11956 |
predicted gene 11956 |
1219 |
0.29 |
chr6_87328302_87328577 | 3.24 |
9530013L04Rik |
RIKEN cDNA 9530013L04 gene |
6100 |
0.11 |
chr6_56901863_56902058 | 3.23 |
Nt5c3 |
5'-nucleotidase, cytosolic III |
74 |
0.96 |
chr2_132689746_132689943 | 3.21 |
Shld1 |
shieldin complex subunit 1 |
313 |
0.82 |
chr5_73311488_73311911 | 3.21 |
Gm42732 |
predicted gene 42732 |
335 |
0.78 |
chr13_23620763_23621788 | 3.21 |
H2bc6 |
H2B clustered histone 6 |
151 |
0.55 |
chr11_87749251_87749406 | 3.21 |
Mir142hg |
Mir142 host gene (non-protein coding) |
6249 |
0.09 |
chr8_79653792_79653943 | 3.21 |
Otud4 |
OTU domain containing 4 |
2125 |
0.27 |
chr15_36716214_36716736 | 3.20 |
Gm49263 |
predicted gene, 49263 |
7172 |
0.15 |
chr2_27207298_27207449 | 3.18 |
Sardh |
sarcosine dehydrogenase |
2564 |
0.2 |
chr8_13075123_13075286 | 3.18 |
Gm17023 |
predicted gene 17023 |
873 |
0.4 |
chr1_131125857_131126184 | 3.16 |
Dyrk3 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 |
12225 |
0.13 |
chr14_25861913_25862081 | 3.15 |
Anxa11os |
annexin A11, opposite strand |
8269 |
0.13 |
chr6_31145797_31145976 | 3.15 |
Gm37728 |
predicted gene, 37728 |
1533 |
0.28 |
chr15_98111923_98112075 | 3.14 |
Pfkm |
phosphofructokinase, muscle |
3533 |
0.15 |
chr1_167368617_167368790 | 3.13 |
Aldh9a1 |
aldehyde dehydrogenase 9, subfamily A1 |
4537 |
0.15 |
chr10_128525093_128526268 | 3.13 |
Esyt1 |
extended synaptotagmin-like protein 1 |
188 |
0.63 |
chr7_141123335_141123932 | 3.13 |
Ptdss2 |
phosphatidylserine synthase 2 |
1251 |
0.24 |
chr17_83836138_83836470 | 3.13 |
Haao |
3-hydroxyanthranilate 3,4-dioxygenase |
336 |
0.87 |
chr13_52822783_52823147 | 3.13 |
BB123696 |
expressed sequence BB123696 |
65760 |
0.12 |
chr11_116616197_116616677 | 3.11 |
Rhbdf2 |
rhomboid 5 homolog 2 |
7763 |
0.1 |
chr2_134724278_134724430 | 3.11 |
Gm14037 |
predicted gene 14037 |
6753 |
0.23 |
chr7_138845608_138846119 | 3.10 |
Ppp2r2d |
protein phosphatase 2, regulatory subunit B, delta |
216 |
0.67 |
chr17_74267470_74267630 | 3.10 |
Memo1 |
mediator of cell motility 1 |
11565 |
0.14 |
chr13_34312744_34312903 | 3.09 |
Gm47086 |
predicted gene, 47086 |
5985 |
0.21 |
chr1_170622997_170623376 | 3.09 |
Gm7299 |
predicted gene 7299 |
7735 |
0.19 |
chr8_123797895_123798249 | 3.08 |
Rab4a |
RAB4A, member RAS oncogene family |
7913 |
0.09 |
chr3_51688706_51689049 | 3.08 |
Gm10729 |
predicted gene 10729 |
4839 |
0.14 |
chr14_26097723_26097874 | 3.08 |
Cphx2 |
cytoplasmic polyadenylated homeobox 2 |
6237 |
0.12 |
chr14_26237336_26237487 | 3.08 |
Cphx3 |
cytoplasmic polyadenylated homeobox 3 |
6239 |
0.13 |
chr14_25957965_25958116 | 3.07 |
Cphx1 |
cytoplasmic polyadenylated homeobox 1 |
3372 |
0.15 |
chr1_86479174_86479713 | 3.07 |
Rpl30-ps6 |
ribosomal protein L30, pseudogene 6 |
5784 |
0.15 |
chr19_6118155_6118821 | 3.06 |
Sac3d1 |
SAC3 domain containing 1 |
162 |
0.83 |
chr1_172311468_172312466 | 3.06 |
Igsf8 |
immunoglobulin superfamily, member 8 |
29 |
0.95 |
chr11_85492227_85492636 | 3.06 |
Bcas3 |
breast carcinoma amplified sequence 3 |
137 |
0.95 |
chr12_70618110_70618261 | 3.05 |
Gm24474 |
predicted gene, 24474 |
31997 |
0.14 |
chr9_69839306_69839465 | 3.04 |
Gm18745 |
predicted gene, 18745 |
46234 |
0.14 |
chr1_75179592_75180552 | 3.04 |
Abcb6 |
ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
214 |
0.81 |
chr1_132477291_132477469 | 3.04 |
Rbbp5 |
retinoblastoma binding protein 5, histone lysine methyltransferase complex subunit |
13 |
0.82 |
chr13_41403888_41404241 | 3.04 |
Gm48570 |
predicted gene, 48570 |
1773 |
0.3 |
chr2_72313431_72313590 | 3.04 |
Map3k20 |
mitogen-activated protein kinase kinase kinase 20 |
15609 |
0.19 |
chr1_82825647_82825996 | 3.04 |
Gm17764 |
predicted gene, 17764 |
2960 |
0.13 |
chr9_32101597_32101753 | 3.03 |
Arhgap32 |
Rho GTPase activating protein 32 |
14461 |
0.15 |
chr17_15053571_15053727 | 3.03 |
Ermard |
ER membrane associated RNA degradation |
590 |
0.67 |
chr10_76537636_76537973 | 3.02 |
Lss |
lanosterol synthase |
4078 |
0.14 |
chr2_173152672_173153088 | 3.00 |
Pck1 |
phosphoenolpyruvate carboxykinase 1, cytosolic |
168 |
0.95 |
chr17_5099300_5099652 | 3.00 |
Gm15599 |
predicted gene 15599 |
12634 |
0.25 |
chr11_97424419_97424730 | 2.99 |
Arhgap23 |
Rho GTPase activating protein 23 |
9041 |
0.16 |
chr16_30502475_30502893 | 2.98 |
Tmem44 |
transmembrane protein 44 |
38225 |
0.14 |
chr16_15368370_15368531 | 2.96 |
Gm21897 |
predicted gene, 21897 |
50992 |
0.13 |
chr5_106964155_106965054 | 2.96 |
Cdc7 |
cell division cycle 7 (S. cerevisiae) |
43 |
0.98 |
chr6_114659319_114659576 | 2.95 |
Atg7 |
autophagy related 7 |
1383 |
0.51 |
chr4_150685000_150685176 | 2.94 |
Gm16079 |
predicted gene 16079 |
6296 |
0.22 |
chr5_22344110_22345571 | 2.93 |
Reln |
reelin |
138 |
0.95 |
chr10_94198550_94199115 | 2.92 |
Ndufa12 |
NADH:ubiquinone oxidoreductase subunit A12 |
112 |
0.96 |
chr2_170158021_170158172 | 2.92 |
Zfp217 |
zinc finger protein 217 |
9993 |
0.28 |
chr19_4462067_4462234 | 2.92 |
Syt12 |
synaptotagmin XII |
9999 |
0.12 |
chr2_155895120_155895281 | 2.92 |
Uqcc1 |
ubiquinol-cytochrome c reductase complex assembly factor 1 |
15404 |
0.12 |
chr2_155613495_155613697 | 2.91 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
2384 |
0.13 |
chr17_66353462_66353614 | 2.91 |
Mtcl1 |
microtubule crosslinking factor 1 |
6993 |
0.19 |
chr4_116101048_116101361 | 2.91 |
Rad54l |
RAD54 like (S. cerevisiae) |
1146 |
0.32 |
chr17_79365519_79365670 | 2.90 |
Cdc42ep3 |
CDC42 effector protein (Rho GTPase binding) 3 |
10503 |
0.22 |
chr7_111179367_111179913 | 2.90 |
1700012D14Rik |
RIKEN cDNA 1700012D14 gene |
56956 |
0.11 |
chr5_122325211_122325362 | 2.90 |
Gm15842 |
predicted gene 15842 |
22864 |
0.08 |
chr11_30166940_30167098 | 2.89 |
Sptbn1 |
spectrin beta, non-erythrocytic 1 |
31238 |
0.19 |
chr3_100436826_100437140 | 2.88 |
Gm43121 |
predicted gene 43121 |
851 |
0.54 |
chr10_20907151_20907354 | 2.88 |
Rps2-ps3 |
ribosomal protein S2, pseudogene 3 |
28279 |
0.18 |
chr2_69135675_69135888 | 2.87 |
Nostrin |
nitric oxide synthase trafficker |
19 |
0.98 |
chr3_144670557_144670708 | 2.86 |
Sh3glb1 |
SH3-domain GRB2-like B1 (endophilin) |
26835 |
0.13 |
chr11_119391808_119391993 | 2.86 |
Rnf213 |
ring finger protein 213 |
1200 |
0.32 |
chr14_14012273_14013624 | 2.86 |
Atxn7 |
ataxin 7 |
196 |
0.95 |
chr3_138442907_138443197 | 2.84 |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
41 |
0.96 |
chr2_29623846_29624043 | 2.84 |
Rapgef1 |
Rap guanine nucleotide exchange factor (GEF) 1 |
4034 |
0.25 |
chr7_75751565_75751723 | 2.83 |
Gm23251 |
predicted gene, 23251 |
5724 |
0.17 |
chr2_75716501_75716667 | 2.83 |
E030042O20Rik |
RIKEN cDNA E030042O20 gene |
11814 |
0.12 |
chr10_95291520_95291671 | 2.82 |
Gm48880 |
predicted gene, 48880 |
23258 |
0.13 |
chr10_44604639_44604790 | 2.82 |
Gm48065 |
predicted gene, 48065 |
2540 |
0.16 |
chr4_139387042_139387343 | 2.82 |
Ubr4 |
ubiquitin protein ligase E3 component n-recognin 4 |
6523 |
0.12 |
chr6_148620615_148620766 | 2.82 |
Gm6313 |
predicted gene 6313 |
6381 |
0.19 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 10.6 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
1.8 | 5.4 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.6 | 7.9 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
1.3 | 3.9 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.3 | 1.3 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
1.3 | 3.8 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
1.2 | 3.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.2 | 3.6 | GO:0040031 | snRNA modification(GO:0040031) |
1.1 | 3.4 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
1.1 | 6.6 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
1.1 | 4.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
1.0 | 3.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.0 | 5.1 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
1.0 | 2.9 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.0 | 2.9 | GO:0097503 | sialylation(GO:0097503) |
1.0 | 2.9 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.9 | 2.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.9 | 3.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.9 | 2.6 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.9 | 3.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.9 | 3.4 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.8 | 2.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.8 | 2.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.8 | 3.2 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.8 | 4.8 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.8 | 3.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.8 | 3.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.7 | 2.2 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.7 | 3.7 | GO:0015886 | heme transport(GO:0015886) |
0.7 | 3.0 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.7 | 2.2 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.7 | 2.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.7 | 2.2 | GO:0008228 | opsonization(GO:0008228) |
0.7 | 3.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.7 | 1.4 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.7 | 2.9 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.7 | 2.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.7 | 7.8 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.7 | 2.8 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.7 | 2.1 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.7 | 2.7 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.7 | 2.0 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.7 | 2.0 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.7 | 2.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.7 | 2.0 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.7 | 2.7 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.7 | 2.0 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.7 | 2.6 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.7 | 1.3 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.7 | 2.0 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.6 | 2.6 | GO:0032264 | IMP salvage(GO:0032264) |
0.6 | 2.6 | GO:0034214 | protein hexamerization(GO:0034214) |
0.6 | 3.8 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.6 | 1.9 | GO:0042117 | monocyte activation(GO:0042117) |
0.6 | 1.9 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.6 | 3.7 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.6 | 1.8 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.6 | 3.7 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.6 | 3.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.6 | 2.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.6 | 1.8 | GO:0002432 | granuloma formation(GO:0002432) |
0.6 | 1.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.6 | 1.7 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.6 | 1.7 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.6 | 1.7 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.6 | 2.8 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.6 | 1.7 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.6 | 5.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.6 | 0.6 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.6 | 2.3 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.6 | 1.7 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.6 | 3.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.6 | 1.7 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.6 | 1.7 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.5 | 2.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.5 | 1.6 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.5 | 1.1 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.5 | 1.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.5 | 1.6 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.5 | 0.5 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.5 | 2.6 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.5 | 4.7 | GO:0034063 | stress granule assembly(GO:0034063) |
0.5 | 1.6 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.5 | 4.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.5 | 2.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.5 | 1.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.5 | 1.5 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.5 | 2.5 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.5 | 1.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.5 | 1.5 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.5 | 0.5 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.5 | 2.0 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.5 | 1.5 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.5 | 3.5 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.5 | 1.5 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 1.0 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.5 | 2.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.5 | 2.4 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.5 | 1.5 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.5 | 1.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.5 | 3.9 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.5 | 1.4 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.5 | 2.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.5 | 1.9 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.5 | 2.4 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.5 | 1.4 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.5 | 1.9 | GO:0033483 | gas homeostasis(GO:0033483) |
0.5 | 1.9 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.5 | 1.9 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.5 | 1.9 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.5 | 2.3 | GO:0009642 | response to light intensity(GO:0009642) |
0.5 | 0.9 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.5 | 1.9 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.5 | 1.8 | GO:0006848 | pyruvate transport(GO:0006848) |
0.4 | 1.3 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.4 | 2.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.4 | 1.8 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.4 | 1.3 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.4 | 1.8 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.4 | 0.9 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.4 | 1.3 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.4 | 1.7 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.4 | 1.7 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.4 | 1.7 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.4 | 3.4 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.4 | 2.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.4 | 0.4 | GO:0070384 | Harderian gland development(GO:0070384) |
0.4 | 0.4 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.4 | 1.7 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.4 | 1.7 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.4 | 0.4 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.4 | 1.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.4 | 2.1 | GO:0060613 | fat pad development(GO:0060613) |
0.4 | 0.8 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.4 | 0.8 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.4 | 13.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.4 | 5.7 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.4 | 1.2 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.4 | 2.0 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.4 | 0.4 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.4 | 0.8 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.4 | 1.6 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.4 | 0.4 | GO:0033121 | regulation of purine nucleotide catabolic process(GO:0033121) |
0.4 | 2.4 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.4 | 3.2 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.4 | 0.8 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.4 | 1.6 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.4 | 2.4 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.4 | 1.6 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.4 | 2.7 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.4 | 1.2 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.4 | 2.3 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.4 | 3.1 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.4 | 1.9 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.4 | 1.5 | GO:0033227 | dsRNA transport(GO:0033227) |
0.4 | 0.8 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.4 | 3.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.4 | 1.5 | GO:0006188 | IMP biosynthetic process(GO:0006188) 'de novo' IMP biosynthetic process(GO:0006189) |
0.4 | 1.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.4 | 1.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.4 | 2.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.4 | 0.7 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.4 | 1.5 | GO:0031506 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.4 | 1.5 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.4 | 0.7 | GO:0072262 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.4 | 1.4 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.4 | 3.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.4 | 0.7 | GO:0035483 | gastric emptying(GO:0035483) |
0.4 | 2.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.4 | 2.5 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.4 | 0.7 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.4 | 0.4 | GO:0036258 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) |
0.4 | 3.9 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.4 | 6.0 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.4 | 1.4 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.3 | 1.0 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.3 | 0.7 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.3 | 0.7 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.3 | 1.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.3 | 1.4 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.3 | 1.0 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.3 | 1.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.3 | 2.4 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.3 | 2.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 1.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.3 | 1.4 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.3 | 3.0 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.3 | 1.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.3 | 0.7 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.3 | 7.7 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.3 | 3.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.3 | 1.7 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.3 | 4.6 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.3 | 0.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.3 | 1.3 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.3 | 1.0 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.3 | 3.3 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.3 | 1.0 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 1.0 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.3 | 1.9 | GO:0044351 | macropinocytosis(GO:0044351) |
0.3 | 0.6 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.3 | 1.0 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.3 | 2.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 1.6 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.3 | 0.6 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.3 | 1.3 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.3 | 1.0 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.3 | 1.3 | GO:0046607 | positive regulation of centrosome duplication(GO:0010825) positive regulation of centrosome cycle(GO:0046607) |
0.3 | 1.6 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.3 | 0.6 | GO:0046931 | pore complex assembly(GO:0046931) |
0.3 | 1.3 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.3 | 1.3 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.3 | 1.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.3 | 0.9 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.3 | 3.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.3 | 1.9 | GO:0060426 | lung vasculature development(GO:0060426) |
0.3 | 1.3 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.3 | 1.3 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 0.9 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.3 | 0.9 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.3 | 0.9 | GO:0048539 | bone marrow development(GO:0048539) |
0.3 | 1.5 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.3 | 0.6 | GO:0051031 | tRNA transport(GO:0051031) |
0.3 | 1.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 0.6 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.3 | 0.9 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.3 | 1.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 0.9 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.3 | 2.7 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.3 | 0.9 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.3 | 0.9 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.3 | 1.5 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.3 | 1.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.3 | 3.0 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.3 | 0.3 | GO:0010039 | response to iron ion(GO:0010039) |
0.3 | 1.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.3 | 1.5 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.3 | 2.1 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.3 | 0.9 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.3 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.3 | 2.4 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 1.2 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.3 | 0.6 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.3 | 0.3 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.3 | 0.9 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.3 | 1.5 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.3 | 0.9 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.3 | 0.3 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.3 | 1.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 1.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.3 | 0.6 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.3 | 2.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 1.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 0.3 | GO:0061511 | centriole elongation(GO:0061511) |
0.3 | 0.8 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.3 | 0.8 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.3 | 0.6 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 0.8 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.3 | 2.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.3 | 0.6 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.3 | 1.4 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.3 | 0.8 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.3 | 1.4 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.3 | 1.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.3 | 0.3 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.3 | 0.8 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.3 | 1.4 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.3 | 1.1 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.3 | 1.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.3 | 0.8 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.3 | 3.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.3 | 0.5 | GO:1903273 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
0.3 | 1.3 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.3 | 1.9 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.3 | 2.1 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.3 | 0.8 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.3 | 1.6 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.3 | 1.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.3 | 0.8 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.3 | 0.3 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.3 | 0.8 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.3 | 1.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.3 | 1.0 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.3 | 1.8 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.3 | 2.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.3 | 1.6 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.3 | 0.3 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.3 | 0.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.3 | 0.8 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 3.6 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.3 | 0.3 | GO:0032079 | positive regulation of deoxyribonuclease activity(GO:0032077) positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.3 | 0.5 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.3 | 0.8 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 0.8 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 1.3 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.3 | 0.8 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.3 | 1.8 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.3 | 0.8 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.3 | 0.8 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.3 | 1.8 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.3 | 0.3 | GO:0034241 | regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
0.2 | 4.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 3.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 1.0 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.2 | 1.0 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.2 | 0.7 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.2 | 0.7 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.2 | 0.7 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 1.0 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
0.2 | 2.2 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.2 | 1.5 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.2 | 0.7 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.2 | 0.5 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 1.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.2 | 0.2 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.2 | 1.4 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.2 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.2 | 1.4 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.2 | 2.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 0.7 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.2 | 1.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 2.4 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.2 | 1.4 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.2 | 3.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.2 | 0.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.5 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 0.9 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 1.6 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.2 | 0.5 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.2 | 0.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 0.9 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.2 | 0.2 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.2 | 1.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 1.4 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 0.7 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.2 | 2.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 0.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 1.8 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.2 | 0.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.2 | 1.4 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 0.5 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 1.8 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.2 | 0.2 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.2 | 1.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 1.3 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.2 | 2.0 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.2 | 0.7 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.7 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.2 | 1.3 | GO:2000104 | negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.2 | 1.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 2.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 0.4 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.2 | 0.2 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.2 | 1.8 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.2 | 0.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.2 | 3.1 | GO:0006903 | vesicle targeting(GO:0006903) |
0.2 | 0.9 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 6.8 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.2 | 1.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.4 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 0.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.2 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.2 | 1.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.2 | 0.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 0.4 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.2 | 0.2 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.2 | 1.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 0.2 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) |
0.2 | 0.9 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.2 | 0.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.2 | 1.1 | GO:0060379 | cardiac muscle cell myoblast differentiation(GO:0060379) |
0.2 | 1.3 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.2 | 0.2 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.2 | 0.2 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.2 | 0.6 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 1.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 0.8 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 1.0 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 0.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 1.2 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.2 | 1.4 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 0.4 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.2 | 0.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 0.4 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.2 | 0.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 0.4 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.2 | 1.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 0.8 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.2 | 0.6 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.4 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.2 | 0.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 0.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.2 | 0.6 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 1.0 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.2 | 0.6 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.2 | 0.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 0.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.2 | 0.6 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.2 | 1.9 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 0.2 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 2.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 0.6 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 1.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 1.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 0.6 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.2 | 0.6 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.2 | 5.1 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 1.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 0.8 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.2 | 1.5 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.2 | 0.8 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 0.8 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.2 | 0.8 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.2 | 0.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 0.2 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.2 | 1.5 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.2 | 0.2 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 3.6 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.2 | 0.7 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.2 | 1.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 4.2 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 0.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.2 | 1.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 0.4 | GO:0043366 | beta selection(GO:0043366) |
0.2 | 0.5 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.2 | 1.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 0.5 | GO:0015817 | histidine transport(GO:0015817) |
0.2 | 3.6 | GO:0007032 | endosome organization(GO:0007032) |
0.2 | 1.6 | GO:0007097 | nuclear migration(GO:0007097) |
0.2 | 0.4 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.2 | 2.7 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.2 | 0.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.5 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.2 | 0.5 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.2 | 0.5 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.2 | 0.4 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.2 | 0.7 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.2 | 0.9 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.2 | 1.9 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 1.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 1.0 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.2 | 3.0 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 0.9 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 1.0 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 0.3 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 1.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 0.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 0.3 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.2 | 1.5 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.2 | 0.5 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.2 | 0.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 0.8 | GO:0018101 | protein citrullination(GO:0018101) |
0.2 | 0.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.8 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.2 | 0.5 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.2 | 0.7 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 1.7 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.2 | 0.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.2 | 0.5 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.2 | 0.2 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.2 | 0.5 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) |
0.2 | 0.8 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.2 | 1.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 1.6 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 0.5 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.2 | 2.9 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.2 | 1.6 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.2 | 0.8 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.2 | 0.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.2 | 0.5 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 3.7 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.2 | 1.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.2 | 0.5 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 1.0 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.2 | 0.3 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.2 | 1.9 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.2 | 0.3 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.2 | 0.5 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.2 | 0.5 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.2 | 0.6 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 1.3 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.2 | 1.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 0.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 0.8 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.5 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 0.6 | GO:0044773 | mitotic DNA damage checkpoint(GO:0044773) |
0.2 | 0.3 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 0.5 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.2 | 0.8 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 0.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 1.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.2 | 0.5 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.2 | 1.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.2 | 0.6 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.2 | 0.5 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.2 | 0.6 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.2 | 4.7 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.2 | 0.2 | GO:0050904 | diapedesis(GO:0050904) |
0.2 | 0.6 | GO:0050996 | positive regulation of lipid catabolic process(GO:0050996) |
0.2 | 0.8 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.1 | 1.6 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.3 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.1 | 0.7 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.1 | 1.2 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.3 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.1 | 1.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 1.0 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 1.6 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.1 | 0.6 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.9 | GO:0002931 | response to ischemia(GO:0002931) |
0.1 | 0.4 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.1 | 0.1 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.1 | 0.1 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.1 | 0.6 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 1.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 2.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.6 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.3 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.1 | 0.4 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 0.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 1.1 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.1 | 0.9 | GO:0043489 | RNA stabilization(GO:0043489) |
0.1 | 0.4 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.1 | 0.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.1 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 0.6 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 2.0 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 1.0 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 1.1 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 7.1 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.1 | 0.6 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 0.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.3 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 1.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 1.4 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.5 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.7 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.1 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 0.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.5 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 0.4 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 1.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.1 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.1 | 0.7 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.1 | 0.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.8 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.4 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.1 | 0.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.4 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.7 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 1.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.3 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 1.4 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 0.3 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
0.1 | 0.4 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.1 | 0.3 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.9 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.5 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.1 | 0.3 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.3 | GO:0036394 | amylase secretion(GO:0036394) |
0.1 | 2.1 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.1 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.6 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.3 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.6 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.5 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.3 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.1 | 1.1 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.3 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.1 | 0.3 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.1 | 0.4 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.2 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.1 | 0.9 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.1 | 0.2 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 1.0 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 1.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.1 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.1 | 0.5 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.4 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.4 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.2 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 0.1 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) response to sodium arsenite(GO:1903935) |
0.1 | 0.8 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.4 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.1 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
0.1 | 0.1 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.4 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.2 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.1 | 1.3 | GO:0046463 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.1 | 0.6 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.4 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 0.5 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.4 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.5 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.1 | 0.1 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.1 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.5 | GO:0035561 | regulation of chromatin binding(GO:0035561) |
0.1 | 0.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.1 | 0.2 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.1 | 0.1 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 0.5 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.2 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.7 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.1 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 0.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.1 | 0.2 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 0.7 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.3 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.2 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 0.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.3 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.1 | 0.3 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.1 | 0.1 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.1 | 0.8 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 0.4 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 0.2 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 0.7 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.4 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.1 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.1 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.3 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.1 | 0.2 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.1 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.4 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.2 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.1 | 0.8 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.1 | 0.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.3 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.5 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.3 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.1 | GO:0034204 | lipid translocation(GO:0034204) |
0.1 | 1.0 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.2 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.1 | 0.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.3 | GO:0031946 | negative regulation of glucocorticoid metabolic process(GO:0031944) regulation of glucocorticoid biosynthetic process(GO:0031946) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.1 | 0.2 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.1 | 0.5 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.4 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.1 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.1 | 0.6 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.3 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.1 | 0.5 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.2 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.1 | 0.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.4 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.6 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.2 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 1.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 1.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.6 | GO:1901889 | negative regulation of cell junction assembly(GO:1901889) |
0.1 | 0.8 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.1 | 0.7 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.1 | 0.6 | GO:1904869 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.1 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.9 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.4 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 1.6 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.3 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 0.4 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.1 | 0.3 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.1 | 0.2 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.1 | 0.6 | GO:0051770 | nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.3 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.1 | 2.1 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.1 | 0.9 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.3 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 1.9 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 1.9 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.7 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.2 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.1 | 3.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.3 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.2 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.2 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.1 | 8.1 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
0.1 | 0.2 | GO:0051294 | establishment of spindle orientation(GO:0051294) |
0.1 | 0.4 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.1 | 0.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.3 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 0.4 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.7 | GO:0070266 | necroptotic process(GO:0070266) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 1.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.7 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 3.6 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.3 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 3.3 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.6 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.1 | 0.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.5 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.4 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 0.2 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.5 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 1.8 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.1 | 0.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 1.3 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.1 | 0.3 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.3 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.5 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.3 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.1 | 0.1 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.1 | 0.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.1 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.3 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.1 | 0.6 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.5 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.1 | 0.7 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 1.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.7 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
0.1 | 0.3 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 0.4 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 0.3 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.2 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.1 | 0.4 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.2 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 0.2 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.4 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
0.1 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
0.1 | 0.2 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.4 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 1.1 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.3 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.1 | 0.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 0.1 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.3 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.1 | 0.1 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
0.1 | 0.2 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.1 | 0.2 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.2 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.6 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.5 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.1 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.1 | 0.2 | GO:0009223 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.5 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.2 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.2 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.6 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.2 | GO:0034143 | regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
0.1 | 0.2 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 0.1 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 0.2 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.3 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.5 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.1 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 0.2 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.1 | 0.7 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.1 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.1 | 0.1 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.1 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.1 | 0.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.1 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.1 | 0.3 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.1 | 0.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 1.1 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.1 | 0.4 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.1 | 0.1 | GO:0070254 | mucus secretion(GO:0070254) |
0.1 | 0.6 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.1 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.1 | 2.7 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.1 | 2.1 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 1.0 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 0.6 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.1 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 0.3 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.8 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.6 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.1 | 0.1 | GO:0042701 | progesterone secretion(GO:0042701) |
0.1 | 0.2 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 0.1 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.1 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.2 | GO:0032736 | positive regulation of interleukin-13 production(GO:0032736) |
0.1 | 0.1 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 1.1 | GO:0051306 | mitotic sister chromatid separation(GO:0051306) |
0.1 | 0.5 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 3.2 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.1 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.1 | 0.5 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.1 | 1.6 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.1 | 0.1 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.1 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.1 | 0.6 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 1.9 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 0.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.3 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.8 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 1.4 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 0.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.1 | GO:0070203 | regulation of establishment of protein localization to telomere(GO:0070203) |
0.1 | 0.1 | GO:0060430 | lung saccule development(GO:0060430) |
0.1 | 0.2 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.1 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 0.1 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 3.1 | GO:0051297 | centrosome organization(GO:0051297) |
0.1 | 0.3 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.1 | 0.8 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.3 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.8 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.1 | 0.3 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 0.1 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.4 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.4 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.1 | 0.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.1 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
0.1 | 0.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.3 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.3 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.2 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.1 | 0.7 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.1 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 3.1 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.1 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) |
0.1 | 0.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.1 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.1 | 0.1 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.3 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.4 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 0.4 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.1 | 0.2 | GO:0050820 | positive regulation of coagulation(GO:0050820) |
0.1 | 0.2 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.1 | 1.1 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.1 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.1 | 0.2 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 0.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.1 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.5 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.1 | 0.6 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.1 | 0.9 | GO:0006094 | gluconeogenesis(GO:0006094) |
0.1 | 0.1 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.1 | 0.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.1 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.1 | 0.3 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.2 | GO:0010841 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.1 | 0.2 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.1 | 0.2 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.1 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.1 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.1 | 0.7 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.4 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.7 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.4 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.4 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 1.1 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.6 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 1.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.1 | GO:0060281 | regulation of oocyte development(GO:0060281) |
0.1 | 0.4 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.1 | 0.1 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.1 | 0.1 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.1 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 4.3 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.2 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 0.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.1 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
0.1 | 0.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:1901983 | regulation of protein acetylation(GO:1901983) |
0.1 | 0.2 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 0.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 0.2 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.1 | 0.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.4 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.1 | 0.1 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.1 | 0.4 | GO:0090199 | regulation of release of cytochrome c from mitochondria(GO:0090199) |
0.1 | 0.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:0035928 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.1 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
0.0 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.0 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.0 | 0.2 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.0 | 0.0 | GO:0009136 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.0 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
0.0 | 0.7 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 0.1 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.0 | 0.8 | GO:0010324 | membrane invagination(GO:0010324) |
0.0 | 0.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.1 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.0 | 0.2 | GO:1901660 | calcium ion export(GO:1901660) |
0.0 | 0.3 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.8 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.0 | 0.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.0 | 0.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.0 | 0.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.0 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
0.0 | 0.2 | GO:0035989 | tendon development(GO:0035989) |
0.0 | 0.0 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.0 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.0 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.0 | 0.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 | 0.7 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 0.1 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.0 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.0 | 0.0 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) regulation of receptor localization to synapse(GO:1902683) |
0.0 | 0.0 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.0 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.5 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.0 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.0 | 0.1 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.0 | 0.4 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.1 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.0 | 0.0 | GO:0050657 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) |
0.0 | 0.1 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.7 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.3 | GO:0033273 | response to vitamin(GO:0033273) |
0.0 | 0.1 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.0 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.0 | 0.0 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.0 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
0.0 | 0.0 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.0 | 0.3 | GO:0030260 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.0 | 0.3 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.1 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.1 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.0 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.7 | GO:0045453 | bone resorption(GO:0045453) |
0.0 | 0.1 | GO:0009118 | regulation of nucleoside metabolic process(GO:0009118) regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) regulation of ATP metabolic process(GO:1903578) |
0.0 | 0.0 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.2 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.0 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.0 | 0.1 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 0.0 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.0 | GO:1904251 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 1.2 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.1 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.0 | 0.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.0 | 0.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.0 | 0.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.2 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.0 | 0.1 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.0 | 0.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.0 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.1 | GO:0016074 | snoRNA metabolic process(GO:0016074) snoRNA processing(GO:0043144) |
0.0 | 1.3 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.0 | 0.1 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
0.0 | 0.1 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.2 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.1 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.0 | 0.5 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.1 | GO:0015793 | glycerol transport(GO:0015793) |
0.0 | 0.0 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.0 | 0.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.0 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.0 | 0.9 | GO:0051168 | nuclear export(GO:0051168) |
0.0 | 0.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.2 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.0 | 0.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.1 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.1 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.0 | 0.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.1 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.0 | 0.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.1 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.0 | 0.1 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.2 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.0 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) |
0.0 | 0.3 | GO:0071467 | cellular response to pH(GO:0071467) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.1 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.0 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
0.0 | 0.1 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.8 | GO:0034728 | nucleosome organization(GO:0034728) |
0.0 | 2.9 | GO:0007059 | chromosome segregation(GO:0007059) |
0.0 | 0.7 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.2 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.0 | 0.2 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.5 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.0 | 0.5 | GO:0051384 | response to glucocorticoid(GO:0051384) |
0.0 | 0.7 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.1 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.0 | 0.5 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.1 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.0 | 0.6 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.0 | 0.0 | GO:0032342 | aldosterone biosynthetic process(GO:0032342) |
0.0 | 0.0 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.0 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.0 | 0.2 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.8 | GO:0016573 | histone acetylation(GO:0016573) |
0.0 | 0.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.2 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.2 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.0 | 0.0 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.0 | 0.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.4 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.0 | 0.0 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.0 | 0.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.3 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 1.8 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.4 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.0 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.0 | 0.2 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.0 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.0 | 0.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.0 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.0 | 0.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.0 | 0.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.0 | 0.0 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.0 | 0.0 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.1 | GO:0071435 | potassium ion export(GO:0071435) |
0.0 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.2 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.3 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.1 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.0 | 0.7 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.0 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.0 | 0.1 | GO:0035268 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) protein mannosylation(GO:0035268) mannosylation(GO:0097502) |
0.0 | 0.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.5 | GO:0010950 | positive regulation of endopeptidase activity(GO:0010950) |
0.0 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.4 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.1 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 2.1 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.4 | GO:0019915 | lipid storage(GO:0019915) |
0.0 | 0.0 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
0.0 | 0.1 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.0 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.1 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.0 | 0.4 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.0 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
0.0 | 0.2 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.0 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.1 | GO:0072012 | renal system vasculature development(GO:0061437) kidney vasculature development(GO:0061440) glomerulus vasculature development(GO:0072012) |
0.0 | 0.0 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.0 | 0.0 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.0 | 0.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.0 | GO:0043038 | amino acid activation(GO:0043038) |
0.0 | 0.0 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.1 | GO:0032108 | negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
0.0 | 0.1 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.0 | 0.0 | GO:0030421 | defecation(GO:0030421) |
0.0 | 0.0 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.0 | 0.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.0 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.0 | 0.0 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.0 | 0.0 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.0 | 0.0 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.0 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.4 | GO:0032869 | cellular response to insulin stimulus(GO:0032869) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.5 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.0 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.0 | 0.0 | GO:0002215 | defense response to nematode(GO:0002215) |
0.0 | 0.0 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.0 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.0 | 0.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.0 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.0 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.0 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.4 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.0 | 0.7 | GO:0006665 | sphingolipid metabolic process(GO:0006665) |
0.0 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.0 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.0 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.0 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.6 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:1901722 | regulation of cell proliferation involved in kidney development(GO:1901722) |
0.0 | 0.6 | GO:0000910 | cytokinesis(GO:0000910) |
0.0 | 0.0 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.0 | 0.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.0 | 0.1 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.1 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.0 | 0.0 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.0 | 0.0 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.0 | 0.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.0 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.0 | 0.9 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.3 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
0.0 | 0.0 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.1 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.0 | 0.0 | GO:0048263 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.0 | 0.0 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.0 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 0.1 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.0 | 0.1 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.0 | 0.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.0 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.0 | 0.3 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.0 | 0.0 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.0 | 0.0 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
0.0 | 0.0 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.0 | 0.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.1 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.0 | 0.0 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.1 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.0 | 0.3 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.1 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.0 | 0.0 | GO:0010677 | negative regulation of cellular carbohydrate metabolic process(GO:0010677) |
0.0 | 0.2 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.0 | GO:0033028 | myeloid cell apoptotic process(GO:0033028) |
0.0 | 0.0 | GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) |
0.0 | 0.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.0 | 0.0 | GO:0060416 | response to growth hormone(GO:0060416) |
0.0 | 0.1 | GO:0006342 | chromatin silencing(GO:0006342) |
0.0 | 0.1 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.1 | GO:0046427 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.0 | 0.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.0 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.0 | 0.0 | GO:0072678 | T cell migration(GO:0072678) |
0.0 | 0.1 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.0 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.0 | 0.0 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.0 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.0 | 0.0 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.0 | 0.0 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.0 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.1 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.0 | 0.0 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.0 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.0 | 0.0 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.0 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.0 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.0 | 0.0 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.0 | 0.0 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.1 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.0 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.0 | 0.0 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.0 | 0.0 | GO:0051610 | serotonin uptake(GO:0051610) |
0.0 | 0.0 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.0 | 0.0 | GO:0009111 | vitamin catabolic process(GO:0009111) diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.0 | GO:0071711 | basement membrane organization(GO:0071711) |
0.0 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.0 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.0 | 0.0 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.0 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.0 | 0.1 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.0 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.0 | 0.0 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.0 | 0.0 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.0 | 0.0 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.0 | 0.0 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 0.0 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.0 | 0.0 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.0 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.0 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.0 | 0.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.0 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.0 | 0.0 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.0 | 0.0 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.9 | 2.6 | GO:0097413 | Lewy body(GO:0097413) |
0.8 | 4.1 | GO:0070695 | FHF complex(GO:0070695) |
0.8 | 3.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.7 | 3.7 | GO:0005638 | lamin filament(GO:0005638) |
0.7 | 4.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.7 | 2.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.7 | 4.0 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.7 | 2.0 | GO:0031523 | Myb complex(GO:0031523) |
0.6 | 3.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.6 | 1.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.6 | 1.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.6 | 2.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.6 | 1.8 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.6 | 1.7 | GO:0097443 | sorting endosome(GO:0097443) |
0.6 | 4.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.5 | 2.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 3.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.5 | 2.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.5 | 3.5 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.5 | 1.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.5 | 1.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.5 | 3.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.5 | 3.9 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.5 | 1.4 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.5 | 2.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.4 | 1.3 | GO:0005745 | m-AAA complex(GO:0005745) |
0.4 | 1.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.4 | 2.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.4 | 13.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.4 | 1.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.4 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.4 | 2.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.4 | 4.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.4 | 2.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.4 | 1.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 1.2 | GO:0031417 | NatC complex(GO:0031417) |
0.4 | 5.0 | GO:0036038 | MKS complex(GO:0036038) |
0.4 | 3.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.4 | 1.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.4 | 1.1 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.4 | 1.5 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.4 | 1.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.4 | 1.5 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 2.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 3.5 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.3 | 2.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.3 | 2.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.3 | 4.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.3 | 2.7 | GO:0001939 | female pronucleus(GO:0001939) |
0.3 | 4.0 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 1.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.3 | 3.9 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 2.6 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 1.6 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 2.5 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 2.5 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.3 | 2.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 0.9 | GO:0035838 | growing cell tip(GO:0035838) |
0.3 | 2.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 1.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 2.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 0.6 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.3 | 2.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 11.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.3 | 2.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 6.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.3 | 0.9 | GO:0030689 | Noc complex(GO:0030689) |
0.3 | 4.8 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 1.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 2.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 1.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.3 | 5.0 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.3 | 1.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 1.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.3 | 1.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.3 | 0.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.3 | 3.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 2.7 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.3 | 2.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 2.7 | GO:0030914 | STAGA complex(GO:0030914) |
0.3 | 0.8 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.3 | 2.1 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 0.8 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.3 | 2.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 6.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.3 | 3.5 | GO:0042599 | lamellar body(GO:0042599) |
0.3 | 1.8 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 1.7 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 0.7 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.2 | 0.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 0.7 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 1.8 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 1.4 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 0.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 0.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 2.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 2.2 | GO:0031011 | Ino80 complex(GO:0031011) |
0.2 | 2.2 | GO:0008278 | cohesin complex(GO:0008278) |
0.2 | 1.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 3.9 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 2.2 | GO:0032797 | SMN complex(GO:0032797) |
0.2 | 0.6 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.2 | 1.9 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 2.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 0.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 0.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.2 | 0.6 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.2 | 1.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 0.4 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 2.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 0.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 11.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 8.1 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 2.2 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 1.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 1.0 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.2 | 1.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 0.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 1.2 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.2 | 0.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 3.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 2.0 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.2 | 1.0 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.2 | 3.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 0.6 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 0.8 | GO:0097346 | INO80-type complex(GO:0097346) |
0.2 | 1.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 2.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.2 | 0.2 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.2 | 2.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 4.0 | GO:0090544 | BAF-type complex(GO:0090544) |
0.2 | 3.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 0.8 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 1.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.6 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 1.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 3.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 0.6 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 0.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 1.3 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 0.6 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.2 | 0.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 2.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.7 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.2 | 1.3 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.2 | 1.4 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 1.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.2 | 0.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 2.5 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 0.3 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 0.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 3.5 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 0.7 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.2 | 1.7 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 0.6 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 2.9 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 0.3 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 9.4 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 3.4 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.2 | 0.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 0.8 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 8.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 9.6 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 1.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 1.8 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.4 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 1.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 2.4 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.1 | 2.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 6.4 | GO:0044438 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.1 | 0.9 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 0.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 2.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 2.3 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 1.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.3 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 1.9 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 11.2 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.3 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.1 | 1.1 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.3 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 0.5 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 3.8 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 1.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 5.3 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.5 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 1.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 2.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.6 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 1.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 12.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 7.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 3.0 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 4.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 1.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 2.9 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.8 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 4.5 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.8 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.3 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 1.5 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 3.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 1.5 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 1.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 1.7 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.1 | 0.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 1.7 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 0.9 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 1.2 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 0.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 3.2 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.9 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 4.2 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.6 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 0.6 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 2.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 1.1 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 1.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 1.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 0.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 10.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 4.1 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.8 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.3 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.3 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 3.4 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 0.1 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 2.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 7.6 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 4.9 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 4.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.3 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
0.1 | 0.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 6.2 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 7.9 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 4.1 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.5 | GO:0031248 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.1 | 0.5 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 1.3 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 0.5 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 1.2 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.5 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 1.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 1.5 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.1 | 1.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 5.6 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 4.2 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 5.4 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 1.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 4.1 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 2.2 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 2.8 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 2.0 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 0.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.6 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 2.2 | GO:0016605 | PML body(GO:0016605) |
0.1 | 3.1 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 8.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.2 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 2.1 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 1.2 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.1 | 0.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 78.6 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.8 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.5 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 24.3 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 5.2 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 0.5 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.9 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 0.8 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.3 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 1.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.2 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.3 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.1 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.1 | 1.4 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.5 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.0 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 1.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 1.2 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.1 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 1.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.0 | GO:0032432 | actin filament bundle(GO:0032432) |
0.0 | 0.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 34.8 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 1.0 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 1.8 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.3 | GO:0035770 | ribonucleoprotein granule(GO:0035770) |
0.0 | 0.2 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.6 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.1 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.4 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.0 | 3.4 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 0.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 2.1 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.0 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
0.0 | 1.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.5 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.0 | GO:0030120 | vesicle coat(GO:0030120) |
0.0 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.1 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.0 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.0 | 0.0 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 1.9 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.5 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 0.0 | GO:0019867 | outer membrane(GO:0019867) organelle outer membrane(GO:0031968) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.0 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.0 | 7.4 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.2 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 1.4 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.2 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.0 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 9.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.1 | 5.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
1.0 | 3.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.9 | 3.8 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.9 | 4.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.9 | 2.8 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.9 | 3.7 | GO:0015232 | heme transporter activity(GO:0015232) |
0.9 | 6.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.9 | 2.7 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.9 | 3.6 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.9 | 2.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.9 | 2.6 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.9 | 3.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.9 | 2.6 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.9 | 0.9 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.8 | 4.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.8 | 3.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.8 | 0.8 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.8 | 4.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.7 | 2.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.7 | 0.7 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.7 | 2.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.6 | 3.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.6 | 3.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.6 | 1.8 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.6 | 3.6 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.6 | 1.8 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.6 | 1.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.6 | 4.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.6 | 4.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.5 | 1.6 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.5 | 3.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.5 | 2.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.5 | 1.5 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.5 | 2.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.5 | 0.5 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.5 | 1.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.5 | 1.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.5 | 2.5 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.5 | 1.4 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.5 | 1.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.5 | 2.9 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.5 | 3.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.5 | 2.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.5 | 1.4 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.5 | 1.9 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.5 | 1.4 | GO:0035877 | death effector domain binding(GO:0035877) |
0.5 | 2.7 | GO:0015288 | porin activity(GO:0015288) |
0.5 | 1.4 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.5 | 2.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.4 | 3.6 | GO:0008430 | selenium binding(GO:0008430) |
0.4 | 4.0 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 0.9 | GO:1990188 | euchromatin binding(GO:1990188) |
0.4 | 0.9 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.4 | 17.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.4 | 1.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 3.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.4 | 1.7 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.4 | 2.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.4 | 0.4 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
0.4 | 7.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.4 | 5.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 1.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.4 | 2.8 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.4 | 2.8 | GO:0046790 | virion binding(GO:0046790) |
0.4 | 0.8 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.4 | 2.0 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.4 | 4.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.4 | 1.5 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.4 | 1.2 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.4 | 2.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.4 | 1.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.4 | 1.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.4 | 1.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.4 | 1.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.4 | 0.4 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.4 | 1.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.4 | 1.5 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.4 | 1.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.4 | 2.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.4 | 1.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.4 | 6.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.4 | 1.5 | GO:0051425 | PTB domain binding(GO:0051425) |
0.4 | 2.5 | GO:0080014 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.4 | 0.7 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.4 | 1.8 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.4 | 2.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.4 | 7.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.4 | 1.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.3 | 0.7 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.3 | 2.4 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.3 | 2.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 4.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 7.5 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.3 | 1.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.3 | 2.7 | GO:0034046 | poly(G) binding(GO:0034046) |
0.3 | 1.0 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.3 | 1.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 2.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.3 | 1.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 2.3 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.3 | 1.3 | GO:0009374 | biotin binding(GO:0009374) |
0.3 | 1.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.3 | 2.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.3 | 0.6 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.3 | 1.9 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.3 | 1.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 1.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.3 | 2.2 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.3 | 1.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.3 | 2.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.3 | 2.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 1.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.3 | 0.6 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.3 | 2.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 2.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 0.9 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 0.9 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 0.9 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.3 | 1.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.3 | 3.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 3.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 1.2 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.3 | 6.3 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.3 | 2.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 0.6 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.3 | 1.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.3 | 1.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.3 | 1.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.3 | 4.1 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.3 | 2.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.3 | 1.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 0.9 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.3 | 10.0 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.3 | 3.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.3 | 4.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.3 | 3.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 0.8 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.3 | 2.0 | GO:0005123 | death receptor binding(GO:0005123) |
0.3 | 5.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.3 | 1.7 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.3 | 1.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 1.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 3.0 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.3 | 1.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 0.3 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.3 | 0.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.3 | 0.5 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.3 | 1.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.3 | 1.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.3 | 1.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.3 | 0.5 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.3 | 2.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.3 | 7.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 5.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 2.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 2.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 1.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 4.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 0.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 0.5 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 2.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 4.1 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 0.7 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.2 | 1.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 1.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 0.9 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 0.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 3.2 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.2 | 0.9 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 3.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 0.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 0.7 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 2.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 0.7 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.2 | 0.9 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 0.7 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 0.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 0.7 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 0.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 10.2 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 0.4 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.2 | 0.7 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 0.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 0.7 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 0.7 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 0.7 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.2 | 1.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.4 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 4.7 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 1.5 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 0.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.6 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 0.4 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 1.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 0.8 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 1.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.6 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.2 | 0.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 0.8 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 1.4 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 0.4 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 0.6 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.2 | 0.6 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
0.2 | 2.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 0.8 | GO:0043559 | insulin binding(GO:0043559) |
0.2 | 3.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 1.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 2.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 1.7 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.2 | 0.8 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.2 | 0.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.2 | 0.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 0.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 2.2 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.2 | 2.8 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 2.5 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 8.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 0.5 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.2 | 1.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 1.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 1.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 0.5 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 0.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 0.5 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 0.3 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 1.7 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 1.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.2 | 0.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 1.7 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 0.8 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 4.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 0.7 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 0.7 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.2 | 0.8 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 3.9 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.2 | 0.5 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 2.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 3.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 1.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 2.8 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 0.8 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 0.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 0.5 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 6.9 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 1.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.6 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.2 | 0.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 1.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 1.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 2.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 0.5 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 0.5 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.2 | 0.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 2.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 0.8 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 0.8 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.2 | 0.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 1.9 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 3.2 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.1 | 1.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 2.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 2.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 1.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 2.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 1.9 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.3 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 0.7 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 1.0 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.4 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 1.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 7.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.8 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.6 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 3.3 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 2.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 1.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 2.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.4 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.4 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.7 | GO:0097617 | annealing activity(GO:0097617) |
0.1 | 2.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.4 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.8 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.4 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 0.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 1.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.9 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 1.0 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.3 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 2.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.4 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.1 | 0.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.9 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 5.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 5.9 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 0.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 2.9 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 2.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 1.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.7 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 2.4 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 2.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 2.5 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.6 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.9 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.8 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 2.3 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.8 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.1 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 1.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.3 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 1.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.5 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 2.1 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 3.0 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 1.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.3 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 2.8 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.1 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 2.4 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 3.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.1 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 0.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.9 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.1 | 5.1 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.1 | 1.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 1.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 1.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 1.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.5 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 11.8 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 1.9 | GO:0015926 | glucosidase activity(GO:0015926) |
0.1 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.4 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 0.8 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.8 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 2.6 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 0.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 1.0 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 0.4 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 6.8 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 0.9 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.1 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.1 | 1.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.9 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 1.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 1.2 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 1.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.8 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 1.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.7 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 1.0 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.7 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.7 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 2.6 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 14.5 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.2 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.8 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 1.5 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.3 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.7 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 1.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.5 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 12.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 1.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.5 | GO:0036442 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) hydrogen-exporting ATPase activity(GO:0036442) |
0.1 | 0.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 1.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 3.9 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.5 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.3 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 0.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 2.4 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 2.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.1 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
0.1 | 1.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.6 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 2.0 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.1 | 2.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.6 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.1 | 0.3 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.3 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 2.2 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 2.0 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.4 | GO:0018448 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.5 | GO:0015922 | aspartate oxidase activity(GO:0015922) D-lysine oxidase activity(GO:0043912) |
0.1 | 0.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.9 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.1 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.1 | 0.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.3 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.1 | 0.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.1 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.1 | 0.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.7 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.2 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.3 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 0.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.2 | GO:0016801 | adenosylhomocysteinase activity(GO:0004013) hydrolase activity, acting on ether bonds(GO:0016801) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 0.5 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 0.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.3 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 1.9 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.3 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.1 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 3.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 1.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 1.0 | GO:0043826 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.0 | 0.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.3 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 1.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.2 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 1.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.0 | 0.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 1.2 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 25.2 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.5 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 1.2 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.0 | 1.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.2 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 2.8 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.0 | 0.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.5 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.6 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.0 | 0.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.1 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.9 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.0 | 0.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.0 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 1.6 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.2 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.0 | 0.3 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.2 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 0.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 1.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.1 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.9 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.1 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.1 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.0 | 0.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 1.2 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.0 | 4.8 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.2 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.0 | 0.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.1 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.0 | 0.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.1 | GO:0015928 | fucosidase activity(GO:0015928) |
0.0 | 5.6 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.3 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.0 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.0 | 0.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 4.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.0 | 0.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.5 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.5 | GO:0016209 | antioxidant activity(GO:0016209) |
0.0 | 0.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.0 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.5 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.4 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0019825 | oxygen binding(GO:0019825) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.1 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 0.7 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.0 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.3 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.0 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 0.0 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 0.0 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.0 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
0.0 | 0.0 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.0 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.2 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 1.0 | GO:0016503 | pheromone receptor activity(GO:0016503) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 6.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.4 | 0.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 3.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.3 | 8.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 6.7 | PID IGF1 PATHWAY | IGF1 pathway |
0.3 | 6.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.3 | 1.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 2.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 7.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.3 | 1.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 1.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.3 | 2.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 4.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 1.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 3.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 2.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 0.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 4.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 3.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 5.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 2.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 4.9 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 2.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 4.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 3.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 7.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 4.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 5.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 8.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 1.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 4.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 4.2 | PID ATM PATHWAY | ATM pathway |
0.2 | 8.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 3.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 0.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 0.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 2.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 0.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 1.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 3.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 3.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 1.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 4.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 0.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 5.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 7.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 5.2 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 2.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 4.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 4.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 3.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 0.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 5.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 1.0 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 4.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 2.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 4.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 2.0 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 1.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 1.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 2.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 4.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 1.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 1.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 2.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 1.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 2.3 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 2.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 1.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.5 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 1.5 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 1.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 1.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 0.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 1.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 2.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 0.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 2.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.3 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.1 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.6 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 4.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 8.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.6 | 5.8 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.6 | 1.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.5 | 3.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 2.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.5 | 4.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.5 | 6.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.5 | 0.5 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.5 | 2.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.5 | 4.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.4 | 6.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 5.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 0.4 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.4 | 4.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 7.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.4 | 3.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 8.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.4 | 6.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 3.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.4 | 1.4 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.3 | 5.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 9.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 1.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 8.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.3 | 3.4 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.3 | 3.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 4.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.3 | 1.7 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.3 | 3.6 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.3 | 3.0 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 2.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.3 | 4.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 4.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.3 | 19.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 4.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 3.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.3 | 10.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 0.5 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.2 | 1.5 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.2 | 3.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 3.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 2.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 2.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 0.5 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 2.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 11.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 2.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 6.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 0.2 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.2 | 2.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 3.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 6.9 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 3.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 4.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 2.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 1.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 1.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 9.4 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.2 | 4.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 2.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 8.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 2.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 2.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 1.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 2.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 2.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 1.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 1.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 2.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 1.8 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 0.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 0.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 15.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 1.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 3.3 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.2 | 2.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 3.8 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 3.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 1.3 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.2 | 1.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 4.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 1.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 1.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 12.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 2.4 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.2 | 2.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 0.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 10.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 3.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 4.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 2.4 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.2 | 0.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 1.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 5.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 2.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 8.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 3.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 7.9 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 2.9 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 2.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 0.3 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.7 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 0.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 2.5 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 1.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 3.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 3.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 0.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 1.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 1.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.2 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 2.5 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 0.7 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 6.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 2.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.2 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 1.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.6 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 0.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.6 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 0.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 1.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 1.7 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 0.2 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 0.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 1.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.8 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 1.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 0.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 1.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 1.7 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 1.6 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.1 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.1 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 6.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.3 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.3 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 0.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.0 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 0.6 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.0 | 0.5 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 2.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 1.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 1.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.2 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 0.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.1 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.0 | 0.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.0 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.3 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 0.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 1.1 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |